Dimension Therapeutics, Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - March 24, 2016

Attached files

file filename
10-K - 10-K - Dimension Therapeutics, Inc.dmtx-10k_20151231.htm
EX-32.1 - EX-32.1 - Dimension Therapeutics, Inc.dmtx-ex321_665.htm
EX-23.1 - EX-23.1 - Dimension Therapeutics, Inc.dmtx-ex231_669.htm
EX-31.1 - EX-31.1 - Dimension Therapeutics, Inc.dmtx-ex311_666.htm
EX-21.1 - EX-21.1 - Dimension Therapeutics, Inc.dmtx-ex211_667.htm
EX-31.2 - EX-31.2 - Dimension Therapeutics, Inc.dmtx-ex312_664.htm
EX-10.15 - EX-10.15 - Dimension Therapeutics, Inc.dmtx-ex1015_668.htm
v3.3.1.900
Label Element Value
Stock Issued During Period Value Vesting Of Restricted Common Stock For Consulting Services dmtx_StockIssuedDuringPeriodValueVestingOfRestrictedCommonStockForConsultingServices $ 8,000
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue 4,000
Stock Issued During Period Value Issued For Services us-gaap_StockIssuedDuringPeriodValueIssuedForServices 81,000
Licensing Fees Paid In Common Stock Value dmtx_LicensingFeesPaidInCommonStockValue 1,800,000
Temporary Equity Accretion To Redemption Value us-gaap_TemporaryEquityAccretionToRedemptionValue (8,000)
Additional Paid In Capital [Member]  
Stock Issued During Period Value Vesting Of Restricted Common Stock For Consulting Services dmtx_StockIssuedDuringPeriodValueVestingOfRestrictedCommonStockForConsultingServices 8,000
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue 4,000
Stock Issued During Period Value Issued For Services us-gaap_StockIssuedDuringPeriodValueIssuedForServices 81,000
Licensing Fees Paid In Common Stock Value dmtx_LicensingFeesPaidInCommonStockValue 1,800,000
Temporary Equity Accretion To Redemption Value us-gaap_TemporaryEquityAccretionToRedemptionValue $ (8,000)
Common Stock [Member]  
Stock Issued During Period Shares Issued For Services us-gaap_StockIssuedDuringPeriodSharesIssuedForServices 153,951
Stock Issued During Period Shares Vesting Of Restricted Common Stock For Consulting Services dmtx_StockIssuedDuringPeriodSharesVestingOfRestrictedCommonStockForConsultingServices 85,528
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross 54,629
Licensing Fees Paid In Common Stock Shares dmtx_LicensingFeesPaidInCommonStockShares 3,421,137
Convertible Preferred Stock [Member]  
Temporary Equity Accretion To Redemption Value us-gaap_TemporaryEquityAccretionToRedemptionValue $ 8,000
Retained Earnings [Member]  
Net Income Loss us-gaap_NetIncomeLoss (3,170,000)
Series A Convertible Preferred Stock [Member] | Convertible Preferred Stock [Member]  
Temporary Equity Stock Issued During Period Value New Issues us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues $ 4,699,000
Temporary Equity Stock Issued During Period Shares New Issues dmtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues 5,000,000

Dimension Therapeutics, Inc. Reports